Home-Based Cardiac Rehabilitation for Heart Failure
(MOBILE HEART Trial)
Trial Summary
What is the purpose of this trial?
The vast majority of individuals with heart failure do not participate in center based cardiac rehabilitation (CBCR). While steps to increase utilization of CBCR are important, many individuals will still not participate for a variety of reasons. This pilot randomized controlled trial is evaluating a home-based cardiac rehabilitation (HBCR) intervention delivered using a custom app and digital tools in patients with heart failure. After a brief roll-in period, participants are randomized to one of two groups: (1) control or (2) HBCR mobile health intervention. The intervention targets key health behaviors and includes traditional cardiac rehabilitation components. The study will assess the effect of the intervention on physical activity, quality of life, clinical events, and other outcomes.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
What data supports the effectiveness of the treatment Home-Based Cardiac Rehabilitation for Heart Failure?
Home-Based Cardiac Rehabilitation (HBCR) has been shown to be beneficial for patients with cardiovascular disease, and studies suggest it can manage cardiovascular risk factors effectively. While specific outcomes for heart failure patients are not fully known, HBCR has been successfully used in other countries and may offer similar benefits to traditional center-based programs.12345
Is home-based cardiac rehabilitation safe for humans?
The safety of home-based cardiac rehabilitation (HBCR) is not well-documented, but it is considered a reasonable option for clinically stable low- to moderate-risk patients who cannot attend traditional programs. More research is needed to fully understand its safety across different patient groups.13456
How is the home-based cardiac rehabilitation treatment different from other treatments for heart failure?
Home-based cardiac rehabilitation (HBCR) is unique because it allows patients to participate in rehabilitation from their own homes, which can increase participation rates compared to traditional center-based programs. It also offers real-time monitoring of exercise and health status, which can help manage heart failure more effectively, especially during times when in-person visits are challenging, like during the COVID-19 pandemic.14578
Research Team
Brian R. Lindman, MD
Principal Investigator
Vanderbilt University Medical Center
Eligibility Criteria
This trial is for individuals with heart failure who are unable to participate in center-based cardiac rehabilitation. Participants must have access to a smartphone or tablet and be willing to use an app and digital tools as part of the intervention.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Roll-in
Participants undergo a brief roll-in period before randomization
Treatment
Participants receive either standard care or home-based cardiac rehabilitation using a mobile health intervention
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Home-Based Cardiac Rehabilitation
Home-Based Cardiac Rehabilitation is already approved in European Union, United States, Canada for the following indications:
- Coronary artery disease
- Heart failure
- Post-myocardial infarction rehabilitation
- Post-percutaneous coronary intervention rehabilitation
- Post-coronary artery bypass grafting rehabilitation
- Coronary artery disease
- Heart failure
- Post-myocardial infarction rehabilitation
- Post-percutaneous coronary intervention rehabilitation
- Post-coronary artery bypass grafting rehabilitation
- Coronary artery disease
- Heart failure
- Post-myocardial infarction rehabilitation
- Post-percutaneous coronary intervention rehabilitation
- Post-coronary artery bypass grafting rehabilitation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Vanderbilt University Medical Center
Lead Sponsor